2007
DOI: 10.1016/j.ajog.2006.08.034
|View full text |Cite
|
Sign up to set email alerts
|

Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
47
3
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(62 citation statements)
references
References 22 publications
10
47
3
2
Order By: Relevance
“…This aspect has not been assessed in other studies. There was no significant differences in mode of delivery, duration of labour and oxytocin requirements during labour in the ISMN treated group, and this is comparable to the findings of previous studies [18][19][20]. The mean induction delivery intervals in the current study were markedly shorter than in the IMOP study and this may be due to the majority of women in the IMOP study having epidural analgesia during labour and the relatively high doses of oxytocin used for IOL in the academic obstetric unit of THMG.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…This aspect has not been assessed in other studies. There was no significant differences in mode of delivery, duration of labour and oxytocin requirements during labour in the ISMN treated group, and this is comparable to the findings of previous studies [18][19][20]. The mean induction delivery intervals in the current study were markedly shorter than in the IMOP study and this may be due to the majority of women in the IMOP study having epidural analgesia during labour and the relatively high doses of oxytocin used for IOL in the academic obstetric unit of THMG.…”
Section: Discussionsupporting
confidence: 81%
“…Therefore outcome measures such as time to vaginal delivery and vaginal delivery not achieved in 24 hours, used for assessment of therapies for IOL, are not appropriate for studies on vaginally administered NO donors. The main advantage [18][19][20]. However in our unit women often self admit themselves to hospital within a day or two of completion of 40 weeks gestation if they have not established SOL.…”
Section: Discussionmentioning
confidence: 99%
“…Although prostaglandins are more effective than ISMN, outpatient use of prostaglandins carries a high risk and is not recommended. Recent studies have demonstrated that ISMN could be safely self administered by women on an outpatient basis [20,21]. The women who participated in these studies had greater maternal satisfaction and were very positive about the opportunity to undertake cervical ripening at home.…”
Section: Introductionmentioning
confidence: 99%
“…Only two studies Bullarbo 2007) collected information on women's views about the induction process, and overall there was very little …”
Section: Summary Of Main Resultsmentioning
confidence: 99%
“…Four trials used sealed, opaque, sequentially numbered envelopes to conceal allocation (Bullarbo 2007;Harper 2006;Larmon 2002;; envelopes were also used in the Meyer 2005 and Stenlund 1999 trials, although in the former it was not stated that they were sealed, and in the latter that they were opaque. In six trials methods to conceal group allocation were not clear (Elliott 1998;Gittens 1996;Hage 1993;Lyons 2001;Newman 1997;Sawai 1991).…”
Section: Risk Of Bias In Included Studiesmentioning
confidence: 99%